JP2000351790A - Production of fucose-containing oligosaccharide, or its composition and fucose-containing oligosaccharide or its composition - Google Patents
Production of fucose-containing oligosaccharide, or its composition and fucose-containing oligosaccharide or its compositionInfo
- Publication number
- JP2000351790A JP2000351790A JP11159715A JP15971599A JP2000351790A JP 2000351790 A JP2000351790 A JP 2000351790A JP 11159715 A JP11159715 A JP 11159715A JP 15971599 A JP15971599 A JP 15971599A JP 2000351790 A JP2000351790 A JP 2000351790A
- Authority
- JP
- Japan
- Prior art keywords
- fucose
- composition
- oligosaccharide
- fucoidan
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、フコースを構成糖
とするフコース含有オリゴ糖又はその組成物の製造法、
及び上記方法によって得られる特定のフコース含有オリ
ゴ糖又はそれを含有するオリゴ糖組成物に関する。The present invention relates to a process for producing a fucose-containing oligosaccharide comprising fucose as a constituent sugar or a composition thereof,
And a specific fucose-containing oligosaccharide obtained by the above method or an oligosaccharide composition containing the same.
【0002】[0002]
【従来の技術】天然において、フコースは海藻細胞壁の
構成成分としてフコイダンの型で含まれているほか、動
物においてはナマコなどの口腔類の体表、高等動物では
細胞間認識などに関与している細胞表層糖鎖の構成糖と
して存在している。2. Description of the Related Art In nature, fucose is contained in the form of fucoidan as a constituent of seaweed cell walls, and is involved in the body surface of oral species such as sea cucumber in animals and intercellular recognition in higher animals. Present as a constituent sugar of cell surface sugar chains.
【0003】近年、糖鎖の生理機能が解明されるにつれ
て、フコースを含有するオリゴ糖の生理機能が注目され
はじめている。[0003] In recent years, as the physiological functions of sugar chains have been elucidated, the physiological functions of oligosaccharides containing fucose have started to attract attention.
【0004】褐藻類から得られるフコイダンは、分岐が
多い高分子であり、構成糖の種類も海藻の種類によって
フコースの他にガラクトースやキシロース、アラビノー
ス、マンノース、グルクロン酸など様々であり、また、
多くのフコイダンでエステル硫酸の結合が様々な位置に
見られるなど、非常に複雑な構造を有するため未だ構造
が確認されていないフコイダンがほとんどである。更
に、フコイダンは海藻の種類だけでなく生育段階、産地
などの環境によっても構成物質が異なると考えられてい
る。[0004] Fucoidan obtained from brown algae is a polymer having a large number of branches, and the type of constituent sugars varies depending on the type of seaweed, such as galactose, xylose, arabinose, mannose, and glucuronic acid.
Most fucoidans have a very complex structure, such as the ester sulfate bond being found at various positions in many fucoidans, and the structure has not yet been confirmed. Further, fucoidan is considered to have different constituent substances depending not only on the type of seaweed but also on the environment such as the stage of growth and the place of production.
【0005】これまでに、海藻から抽出・精製されたフ
コイダンのメチル化分析による構造解析の結果から、フ
コシルフコースの二糖単位が存在していることが知られ
ている(Journal of Chemical Society 2248−2254 (19
59))。From the results of structural analysis by methylation analysis of fucoidan extracted and purified from seaweed, it has been known that a disaccharide unit of fucosyl fucose is present (Journal of Chemical Society 2248-). 2254 (19
59)).
【0006】しかしながら、海藻類から構造の明確なフ
コース含有オリゴ糖を抽出分離精製した報告はなされて
おらず、単糖のフコースを原料とした化学合成によるフ
コース含有オリゴ糖の調製方法が報告されている(Carb
ohydrate Research 4, 189−195 (1967)、Carbohydrate
Research 37, 75−79 (1974)、Carbohydrate Research
41, 308−312 (1975))だけであった。[0006] However, no report has been made on the extraction, separation and purification of fucose-containing oligosaccharides having a clear structure from seaweeds. A method for preparing fucose-containing oligosaccharides by chemical synthesis using monosaccharide fucose as a raw material has been reported. (Carb
ohydrate Research 4, 189-195 (1967), Carbohydrate
Research 37, 75-79 (1974), Carbohydrate Research
41, 308-312 (1975)).
【0007】[0007]
【発明が解決しようとする課題】しかしながら、上記化
学合成による調製方法は、原料に用いる単糖のフコース
をフコイダンの完全加水分解により調製しなければなら
ず、また有機合成反応による多段階の修飾、保護、脱保
護反応、各ステップ毎のクロマトカラムによる分離精製
が必要になるなど工程が非常に煩雑であり収率も低かっ
た。更に、これらのフコース含有オリゴ糖類は、有機合
成反応により調製されている為、食品に使用することが
できなかった。However, in the above-mentioned preparation method by chemical synthesis, the monosaccharide fucose used as a raw material must be prepared by complete hydrolysis of fucoidan, and multi-stage modification by organic synthesis reaction is required. The steps were very complicated and required low yields, such as the need for protection and deprotection reactions, and separation and purification using a chromatographic column for each step. Furthermore, these fucose-containing oligosaccharides cannot be used in foods because they are prepared by an organic synthesis reaction.
【0008】このため、食品にも利用できるフコース含
有オリゴ糖類の効率的調製方法の開発が嘱望されていた
が、海藻を原料として構造の明確なフコースを含有する
オリゴ糖類を安定して生産することは困難であった。[0008] For this reason, there has been a demand for the development of an efficient method for preparing fucose-containing oligosaccharides that can be used in foods. However, it has been desired to stably produce oligosaccharides containing fucose with a clear structure using seaweed as a raw material. Was difficult.
【0009】したがって、本発明の目的は、養殖生産に
より安定して入手が容易な褐藻類から得られるフコイダ
ンを原料として、構造が明確で、食品、試薬、医薬品等
の幅広い用途に利用可能なフコース含有オリゴ糖又はそ
れを含有するオリゴ糖組成物を効率的に製造する方法、
及び該方法によって得られる特定のフコース含有オリゴ
糖又はそれを含有するオリゴ糖組成物を提供することに
ある。[0009] Therefore, an object of the present invention is to provide a fucoidan, which is obtained from brown algae which is stable and easily available through aquaculture production, and has a clear structure and can be used for a wide range of applications such as foods, reagents and pharmaceuticals. A method for efficiently producing an oligosaccharide-containing or oligosaccharide composition containing the same,
And a specific fucose-containing oligosaccharide obtained by the method or an oligosaccharide composition containing the same.
【0010】[0010]
【課題を解決するための手段】上記目的を達成するため
に本発明者らは、安価で大量にかつ容易に入手できる海
藻のなかで、それに含まれるフコイダンの構成糖組成が
比較的単純であるものを検索した。そして、ナガマツモ
科(Chordariaceae)又はモズク科(Spermatochnacea
e)の海藻から抽出分離精製して得られた精製フコイダ
ンを適当な酸分解条件で加水分解することにより、特定
のフコース含有オリゴ糖又はそれを含有するオリゴ糖組
成物が効率よく生成することを見出し、本発明を完成す
るに至った。Means for Solving the Problems In order to achieve the above-mentioned object, the present inventors have found that among the seaweeds which are inexpensive, available in large quantities and easily, the sugar composition of fucoidan contained therein is relatively simple. Searched for things. And the family Sagamo (Chordariaceae) or Mozuku (Spermatochnacea)
e) By hydrolyzing the purified fucoidan obtained by extraction / separation from seaweed under suitable acidolysis conditions, it is possible to efficiently produce a specific fucose-containing oligosaccharide or an oligosaccharide composition containing the same. As a result, the present invention has been completed.
【0011】すなわち、本発明のフコース含有オリゴ糖
又はその組成物の製造法は、ナガマツモ科(Chordariac
eae)又はモズク科(Spermatochnaceae)の海藻から抽
出して得られるフコイダンを酸加水分解後、フコース含
有オリゴ糖又はその組成物を分離精製することを特徴と
する。[0011] That is, the process for producing the fucose-containing oligosaccharide or the composition thereof of the present invention is carried out by the method of Chordariac family.
euc) or fucoidan obtained by extracting from seaweeds of the family Spermatochnaceae is subjected to acid hydrolysis, and then the fucose-containing oligosaccharide or a composition thereof is separated and purified.
【0012】この場合、前記海藻として、モズク科のモ
ズク(Nemacystis decipiens (Suringar) Kuckuck)を
使用することが好ましい。In this case, it is preferable to use a mozuku (Nemacystis decipiens (Suringar) Kuckuck) belonging to the family Mozuku as the seaweed.
【0013】また、前記フコース含有オリゴ糖又はその
組成物が、下記化学式4で表されるフコシル−α1,3
−フコース又はそれを含有するオリゴ糖組成物であるこ
とが好ましい。Further, the fucose-containing oligosaccharide or a composition thereof is a fucosyl-α1,3 represented by the following chemical formula 4.
-It is preferably fucose or an oligosaccharide composition containing it.
【0014】[0014]
【化4】 Embedded image
【0015】更に、前記フコース含有オリゴ糖又はその
組成物が、下記化学式5で表されるキシロシル−β1,
2−フコース又はそれを含有するオリゴ糖組成物である
ことが好ましい。Further, the fucose-containing oligosaccharide or a composition thereof is a xylosyl-β1,
It is preferably 2-fucose or an oligosaccharide composition containing it.
【0016】[0016]
【化5】 Embedded image
【0017】また、本発明のフコース含有オリゴ糖又は
その組成物は、前記化学式5で示されるキシロシル−β
1,2−フコース又はそれを含有するオリゴ糖組成物で
あることを特徴とする。Further, the fucose-containing oligosaccharide of the present invention or the composition thereof comprises the xylosyl-β represented by the above-mentioned formula (5).
It is 1,2-fucose or an oligosaccharide composition containing the same.
【0018】本発明によれば、構造の明確なフコース含
有オリゴ糖又はそれを含有するオリゴ糖組成物を、天然
物であるフコイダンの部分加水分解物として得ることが
できるため、これらを食品素材として利用することがで
きる。また、フコース含有オリゴ糖として、構造の明確
な単一のオリゴ糖を得ることができるため、フコイダン
関連化合物分解酵素の活性測定用基質や、糖鎖工学分野
における合成原料としても用いることができる。According to the present invention, a fucose-containing oligosaccharide having a well-defined structure or an oligosaccharide composition containing the same can be obtained as a partial hydrolyzate of fucoidan, which is a natural product, and these are used as food materials. Can be used. In addition, since a single oligosaccharide having a clear structure can be obtained as a fucose-containing oligosaccharide, it can be used as a substrate for measuring the activity of a fucoidan-related compound-degrading enzyme or as a raw material for synthesis in the field of sugar chain engineering.
【0019】[0019]
【発明の実施の形態】本発明に用いられる原料の海藻と
しては、それに含まれるフコイダンの構成糖組成が比較
的単純で、かつ大量に安定して入手可能なものが好まし
い。例えば、ウロン酸を多く含むフコイダンを加水分解
した場合、生成したオリゴ糖がウロン酸残基を含むもの
である確率が高く、目的とするオリゴ糖類の収率を極め
て悪くするため好ましくない。BEST MODE FOR CARRYING OUT THE INVENTION As a raw material of seaweed used in the present invention, fucoidan contained in the seaweed is preferably relatively simple, and is preferably stably available in large quantities. For example, when fucoidan containing a large amount of uronic acid is hydrolyzed, it is not preferable because the generated oligosaccharide has a high probability of containing a uronic acid residue, which extremely deteriorates the yield of the target oligosaccharide.
【0020】具体的には、ウロン酸残基をほとんど含ん
でいないフコイダンを含む褐藻類が好ましく、特にモズ
ク、オキナワモズクが好ましく用いられる。該モズク
は、天然物でも養殖物でも良いが、安定供給と構成糖組
成の安定の為には養殖モズクの使用が望ましい。本発明
に用いる場合、採取したこれらの海藻を軽く水洗してそ
のまま使用することが好ましい。Specifically, brown algae containing fucoidan containing almost no uronic acid residue are preferred, and mozuku and Okinawa mozuku are particularly preferred. The mozuku may be a natural product or a cultured product, but it is preferable to use a cultured mozuku for stable supply and stable sugar composition. When used in the present invention, it is preferable that these collected seaweeds are washed lightly with water and used as they are.
【0021】・フコイダンの抽出方法 本発明において、上記原料の海藻からフコイダンを抽出
する方法としては、上記原料に、塩酸、硫酸、硝酸、リ
ン酸等の無機酸、又は、酢酸、クエン酸、シュウ酸、コ
ハク酸、ギ酸、プロピオン酸等の有機酸の水溶液を、p
H1〜5、原料濃度が乾燥物として0.1〜3重量%と
なるように加え、10〜100℃にて0〜24時間撹拌
して抽出する方法が挙げられる。好ましくは、上記原料
に、塩酸を、pH2〜3、原料濃度が乾燥物として2〜
3重量%となるように加え、20〜30℃にて15〜2
0時間抽出する。更に好ましくは、ミキサーなどで原料
を粉砕してから抽出を行う。-Method for extracting fucoidan In the present invention, as a method for extracting fucoidan from the above-mentioned raw material seaweed, an inorganic acid such as hydrochloric acid, sulfuric acid, nitric acid, phosphoric acid or the like, or acetic acid, citric acid, or shu An aqueous solution of an organic acid such as acid, succinic acid, formic acid, propionic acid,
H1-5, a method in which the raw material concentration is 0.1-3% by weight as a dry matter, and the mixture is extracted by stirring at 10-100 ° C for 0-24 hours. Preferably, hydrochloric acid is added to the above-mentioned raw material at a pH of 2 to 3 and the raw material concentration is 2 to 3 as a dry product.
3% by weight, and 15 to 2 at 20 to 30 ° C.
Extract for 0 hours. More preferably, the raw material is pulverized with a mixer or the like before extraction.
【0022】このようにして得られた抽出液を濾過し
て、アルカリ剤によりpH7〜8に中和後、固形分濃度
が1〜30重量%になるまで減圧濃縮する。該濃縮液に
2〜4重量倍のエタノールを添加して0〜24時間冷蔵
・静置した後、遠心して沈殿物を回収・乾燥することに
より粗フコイダンを得ることができる。The extract thus obtained is filtered, neutralized to pH 7 to 8 with an alkaline agent, and concentrated under reduced pressure until the solid content concentration becomes 1 to 30% by weight. A crude fucoidan can be obtained by adding 2 to 4 times by weight of ethanol to the concentrated solution, refrigerated and allowed to stand for 0 to 24 hours, and then centrifuging to collect and dry the precipitate.
【0023】本発明において酸加水分解に用いるフコイ
ダンの純度は必ずしも高い必要はなく、フコース含有オ
リゴ糖の分離精製に支障がなければ上記粗抽出物でも使
用できるが、精製工程の簡易化のためには以下のように
して調製される精製フコイダンを使用することが好まし
い。In the present invention, the purity of fucoidan used for acid hydrolysis is not necessarily required to be high, and the above crude extract can be used as long as the separation and purification of the fucose-containing oligosaccharide is not hindered. It is preferable to use purified fucoidan prepared as follows.
【0024】上記粗フコイダンを30〜100重量倍の
脱塩水に溶解後、塩化セチルピリジニウム(以下、CP
Cという)を1〜6重量%、好ましくは2〜5重量%に
なるように添加して、室温で10〜20時間撹拌した
後、遠心して沈殿物を回収する。この沈殿物を2〜60
重量倍の4M塩化カルシウム液に溶解させ、不溶物を濾
過により除去した後、2〜3重量倍のエタノールを加え
て撹拌した後、4〜25℃で2〜8時間静置し、遠心し
て沈殿物を回収・乾燥することにより精製フコイダンを
得ることができる(Agricultural and Biological Chem
istry Vol.30, No.5, p.495−499, 1966参照)。After dissolving the above crude fucoidan in 30 to 100 times by weight of demineralized water, cetylpyridinium chloride (hereinafter referred to as CP)
C), and the mixture is stirred at room temperature for 10 to 20 hours and then centrifuged to collect a precipitate. This sediment is
After dissolving in 4 times by weight of 4M calcium chloride solution, removing insolubles by filtration, adding 2 to 3 times by weight of ethanol, stirring, leaving still at 4 to 25 ° C for 2 to 8 hours, centrifuging to precipitate. Purified fucoidan can be obtained by collecting and drying the substance (Agricultural and Biological Chem
istry Vol. 30, No. 5, p. 495-499, 1966).
【0025】・フコイダンの加水分解 上記のようにして得られたフコイダン、好ましくは精製
フコイダンを原料として、塩酸、硫酸、硝酸、リン酸等
の無機酸や、酢酸、クエン酸、シュウ酸、コハク酸、ギ
酸、プロピオン酸等の有機酸の存在下で加水分解を行
う。加水分解条件の好ましい例としては、0.01〜1
2N、好ましくは0.2〜1.0Nの塩酸を、フコイダ
ンの濃度が0.01〜10重量%、好ましくは0.2〜
1.0重量%で、pHが0.1〜1.0、好ましくは
0.1〜0.5となるように加え、20℃〜100℃、
好ましくは75〜85℃で、0〜24時間、好ましくは
0.5〜2時間加水分解反応させる。Hydrolysis of fucoidan Using fucoidan obtained as described above, preferably purified fucoidan as a raw material, inorganic acids such as hydrochloric acid, sulfuric acid, nitric acid, phosphoric acid, acetic acid, citric acid, oxalic acid, and succinic acid The hydrolysis is carried out in the presence of an organic acid such as formic acid, propionic acid and the like. Preferred examples of the hydrolysis conditions include 0.01 to 1
2N, preferably 0.2-1.0N hydrochloric acid, fucoidan concentration of 0.01-10% by weight, preferably 0.2-1.0%
At 1.0% by weight, the pH is added so as to be 0.1 to 1.0, preferably 0.1 to 0.5.
The hydrolysis reaction is carried out preferably at 75 to 85 ° C for 0 to 24 hours, preferably 0.5 to 2 hours.
【0026】反応終了後、速やかに反応液を冷却し、水
酸化ナトリウム、炭酸ナトリウム等のアルカリ剤により
pH7〜8に中和する。この中和液を活性炭脱色、濾
過、電気透析装置による脱塩することにより、フコース
含有オリゴ糖組成物を得ることができる。After the completion of the reaction, the reaction solution is immediately cooled and neutralized to pH 7 to 8 with an alkali agent such as sodium hydroxide or sodium carbonate. The neutralized solution is decolorized with activated carbon, filtered, and desalted with an electrodialysis device to obtain a fucose-containing oligosaccharide composition.
【0027】・フコース含有オリゴ糖の精製 上記組成物を「Dowex1×4」(商品名、ザ・ダウ
・ケミカル・カンパニー社製)、「DEAE−Seph
adex A−25」(商品名、アマシャムファルマシ
アバイオテク製)等の陰イオン交換樹脂カラムに通し、
素通り画分を回収する。該素通り画分を更に活性炭カラ
ムに通して単糖類を除去し、オリゴ糖画分を得る。Purification of Fucose-Containing Oligosaccharides The above-mentioned composition was used as “Dowex 1 × 4” (trade name, manufactured by The Dow Chemical Company), “DEAE-Seph”
adex A-25 "(trade name, manufactured by Amersham Pharmacia Biotech) and the like.
Collect the flow through fraction. The flow-through fraction is further passed through an activated carbon column to remove monosaccharides to obtain an oligosaccharide fraction.
【0028】このオリゴ糖画分を、例えば、NH2カラ
ムを用いたHPLC分取クロマトグラフィーに供し、分
画・精製することによりフコース含有オリゴ糖を得るこ
とができる。The oligosaccharide fraction is subjected to, for example, HPLC preparative chromatography using an NH 2 column to fractionate and purify, whereby a fucose-containing oligosaccharide can be obtained.
【0029】このような方法で得られるフコース含有オ
リゴ糖の一つは、前記化学式4で示されるフコシル−α
1,3−フコースであり、別の一つは、前記化学式5で
示されるキシロシル−β1,2−フコースであることが
確認された。One of the fucose-containing oligosaccharides obtained by such a method is the fucosyl-α represented by the above formula (4).
1,3-fucose, and another was confirmed to be xylosyl-β1,2-fucose represented by Chemical Formula 5.
【0030】こうして得られるフコイダン含有オリゴ糖
又はその組成物は、例えばフコイダン関連化合物分解酵
素の活性測定用基質、α−フコシダーゼの活性測定用基
質、β−キシロシダーゼの活性測定用基質、又は阻害剤
などの試薬類、診断薬、スチレンなどの合成高分子に組
み込むことによる医療材料への用途、医薬品の組成物又
は合成原料として、また、乳酸菌の増殖促進を目的とし
た腸内環境改善物質としての健康食品、病原菌の感染防
止を目的とした衛生食品などに添加、配合する目的で、
又は食品添加物、化粧品素材、入浴剤用素材などのトイ
レタリー製品へ使用することができる。The thus obtained fucoidan-containing oligosaccharide or composition thereof may be, for example, a substrate for measuring the activity of a fucoidan-related compound-degrading enzyme, a substrate for measuring the activity of α-fucosidase, a substrate for measuring the activity of β-xylosidase, an inhibitor, etc. For use as a medical material by incorporating it into reagents, diagnostic agents, synthetic polymers such as styrene, as a pharmaceutical composition or synthetic raw material, and as an intestinal environment improving substance for the purpose of promoting the growth of lactic acid bacteria For the purpose of adding and blending in foods, sanitary foods etc. for the purpose of preventing infection of pathogenic bacteria,
Or it can be used for toiletry products such as food additives, cosmetic materials, and materials for bath additives.
【0031】[0031]
【実施例】以下、実施例を挙げて本発明を具体的に説明
するが、本発明はこれらによって制限されるものではな
い。EXAMPLES The present invention will now be described specifically with reference to examples, but the present invention is not limited by these examples.
【0032】試験例 海藻類の分析調査は、日本沿岸などで入手できる海藻類
(褐藻類)について行った。試料として、市販品(生)
のワカメ、ヒジキ、コンブ、モズク、オキナワモズクと
近海で採取されたホンダワラ、ヨレモク、カジメ、アラ
メを使用した。Test Example An analysis of seaweeds was carried out on seaweeds (brown algae) available on the coast of Japan. Commercial sample (raw) as sample
Wakame, Hijiki, Kombu, Mozuku, Okinawa mozuku, and Hondawara, Yolemoku, Kajime and Alame collected from near seas were used.
【0033】各海藻から常法によりフコイダンを抽出分
離精製し、各フコイダンを塩酸加水分解、脱塩した後、
HPLC分析を行い、それぞれのフコイダンの構成糖分
析(フコース含量、中性糖組成)を行った。その結果、
モズクとオキナワモズクの2つがフコースの含量が比較
的高く、キシロースやマンノース、グルコースなどの他
の中性糖の含量が低いことが分かった。更に、モズクと
オキナワモズクについてウロン酸含量、硫酸基含量など
を測定し、その結果を表1に示した。After extracting and purifying fucoidan from each seaweed by a conventional method, and hydrolyzing and desalting each fucoidan with hydrochloric acid,
HPLC analysis was performed, and constituent sugar analysis (fucose content, neutral sugar composition) of each fucoidan was performed. as a result,
Mozuku and Okinawa mozuku were found to have relatively high fucose contents and low contents of other neutral sugars such as xylose, mannose and glucose. Further, uronic acid content, sulfate group content and the like were measured for mozuku and Okinawa mozuku, and the results are shown in Table 1.
【0034】表1から、モズク(Nemacystis decipiens
(Suringar) Kuckuck)由来のフコイダンはウロン酸含
量が低く、中性糖組成に占めるフコース含量が高いこと
からフコース含有オリゴ糖を調製する際の原料として最
適であることが分かった。From Table 1, it can be seen that Mozuku (Nemacystis decipiens)
Fucoidan derived from (Suringar) Kuckuck) has a low uronic acid content and a high fucose content in the neutral sugar composition, indicating that it is optimal as a raw material for preparing a fucose-containing oligosaccharide.
【0035】[0035]
【表1】 [Table 1]
【0036】実施例1 (1)フコイダンの抽出 生モズク10kgに0.2N塩酸30Lを加え、クッキ
ングミキサー破砕した後、撹拌しながら25℃で18時
間抽出を行った。この溶液を濾過して抽出残渣を除いた
後、2N水酸化ナトリウム溶液でpH7.5に中和し、
不溶物を濾過して除去した後、液量が4Lになるまで真
空加熱濃縮を行った。この濃縮液にエタノール8Lを添
加撹拌し、18時間冷蔵・静置した後、遠心分離(1
0,000×g、15分)して沈殿物を回収し、真空乾
燥して粗フコイダン153gを得た。Example 1 (1) Extraction of fucoidan To 10 kg of raw mozuku, 30 L of 0.2N hydrochloric acid was added, and the mixture was crushed with a cooking mixer, followed by extraction at 25 ° C. for 18 hours with stirring. This solution was filtered to remove extraction residues, and then neutralized to pH 7.5 with 2N sodium hydroxide solution.
After removing the insoluble matter by filtration, the solution was concentrated by heating under vacuum until the liquid amount became 4 L. Eight liters of ethanol was added to this concentrated solution, stirred, refrigerated and allowed to stand for 18 hours, and then centrifuged (1
(000 × g, 15 minutes), and the precipitate was collected and dried under vacuum to obtain 153 g of crude fucoidan.
【0037】(2)フコイダンの分離精製 得られた粗フコイダン153gを脱塩水5Lに溶解し、
CPC 215gを添加して室温で18時間撹拌した
後、遠心分離(10、000×g、15分)して沈殿物
を回収した。該沈殿物を4M塩化カルシウム溶液8Lに
溶解させて18時間撹拌した後、セライトを用いて濾過
して不溶物を除去した。得られた溶液にエタノール24
Lを添加撹拌し、6時間冷却した後、上記と同様に遠心
分離して沈殿物を回収した。この沈殿物を脱塩水1.5
Lに溶解させ、透析チューブを用いて脱塩した。透析液
を0.5N水酸化ナトリウムでpH7.1〜7.5に調
整後、凍結乾燥して精製フコイダン36.5gを得た。(2) Separation and purification of fucoidan 153 g of the obtained crude fucoidan was dissolved in 5 L of deionized water,
After adding 215 g of CPC and stirring at room temperature for 18 hours, the precipitate was collected by centrifugation (10,000 × g, 15 minutes). The precipitate was dissolved in 8 L of a 4 M calcium chloride solution, stirred for 18 hours, and then filtered using celite to remove insolubles. Ethanol 24 was added to the resulting solution.
L was added, stirred, cooled for 6 hours, and centrifuged in the same manner as above to collect a precipitate. This precipitate is deionized water 1.5
L and desalted using a dialysis tube. The dialysate was adjusted to pH 7.1 to 7.5 with 0.5N sodium hydroxide, and then freeze-dried to obtain 36.5 g of purified fucoidan.
【0038】(3)フコイダンの加水分解 上記精製フコイダン8gを0.5N塩酸1.6Lに溶解
し、撹拌しながら80℃で1時間加水分解を行った。こ
の反応液を冷却後、1〜4Nの水酸化ナトリウムでpH
7.5に中和し、活性炭(和光純薬製)5gを添加して
1時間撹拌して脱色した。0.45μmメンブランフィ
ルターを用いて濾過して活性炭を除去した後、マイクロ
アシライザー(旭化成工業製)で脱塩し、凍結乾燥して
フコイダン加水分解物11.6gを得た。(3) Hydrolysis of fucoidan 8 g of the above purified fucoidan was dissolved in 1.6 L of 0.5N hydrochloric acid and hydrolyzed at 80 ° C. for 1 hour with stirring. After cooling the reaction solution, pH was adjusted with 1 to 4N sodium hydroxide.
The mixture was neutralized to 7.5, 5 g of activated carbon (manufactured by Wako Pure Chemical Industries, Ltd.) was added, and the mixture was stirred for 1 hour to be decolorized. After filtering through a 0.45 μm membrane filter to remove activated carbon, desalting was performed with a micro-acyler (Asahi Kasei Kogyo) and freeze-dried to obtain 11.6 g of fucoidan hydrolyzate.
【0039】(4)フコース含有オリゴ糖類の分離精製 上記フコイダン加水分解物2.9gを蒸留水0.1Lに
溶解後、「Dowex1×4(200−400mes
h)」(商品名、ザ・ダウ・ケミカル・カンパニー社
製)カラムクロマトグラフィーに供し、素通り画分を回
収した。この回収画分をそのまま、以下の条件で活性炭
−セライトカラムクロマトグラフィーに供してオリゴ糖
画分を分画した。(4) Separation and Purification of Fucose-Containing Oligosaccharides After dissolving 2.9 g of the fucoidan hydrolyzate in 0.1 L of distilled water, "Dowex 1 × 4 (200-400mes)
h) "(trade name, manufactured by The Dow Chemical Company) and subjected to column chromatography to collect a flow-through fraction. This collected fraction was directly subjected to activated carbon-celite column chromatography under the following conditions to fractionate an oligosaccharide fraction.
【0040】 カラム:活性炭(和光純薬製):セライト(和光純薬
製)=20g:20g 流速:1.6ml/分 温度:25℃ 検出波長:490nm(フェノール硫酸法) 溶媒A:蒸留水 溶媒B:エタノール 濃度勾配:0〜30%B/840分 その結果を図1に示す。図1中、F−1に示す画分(2
糖画分)を回収、濃縮して、更に以下の条件で分取HP
LCクロマトグラフィーを行った。Column: activated carbon (manufactured by Wako Pure Chemical): Celite (manufactured by Wako Pure Chemical) = 20 g: 20 g Flow rate: 1.6 ml / min Temperature: 25 ° C. Detection wavelength: 490 nm (phenol sulfate method) Solvent A: distilled water Solvent B: ethanol Concentration gradient: 0 to 30% B / 840 minutes The results are shown in FIG. In FIG. 1, the fraction (2) shown as F-1
The sugar fraction) is collected, concentrated, and further fractionated under the following conditions.
LC chromatography was performed.
【0041】 カラム:「Asahipak NH2P−90(21.
5φ×300L)」(商品名、昭和電工製) 流速:4ml/分 温度:25℃ 検出器:示差屈折計 溶媒:水:アセトニトリル=1:4 その結果を図2に示す。図2中、F−1a及びF−1b
に示す画分をそれぞれ回収して凍結乾燥してF−1a画
分3mg、F−1b画分2.7mgを得た。Column: “Asahipak NH2P-90 (21.
5φ × 300 L) ”(trade name, manufactured by Showa Denko) Flow rate: 4 ml / min Temperature: 25 ° C. Detector: differential refractometer Solvent: water: acetonitrile = 1: 4 The results are shown in FIG. In FIG. 2, F-1a and F-1b
Were collected and lyophilized to obtain 3 mg of F-1a fraction and 2.7 mg of F-1b fraction.
【0042】(5)核磁気共鳴分析 上記F−1a画分、F−1b画分について核磁気共鳴分
析を行った。その結果を図3及び4に示す。(5) Nuclear magnetic resonance analysis Nuclear magnetic resonance analysis was performed on the F-1a fraction and the F-1b fraction. The results are shown in FIGS.
【0043】図3は、F−1a画分(フコシル−α1,
3−フコース)のC-H COSY Spectrum を示す図である。
重水中、30℃で測定した結果について、縦軸にC13のD
ownfield shiftを、横軸にH1のDownfield shiftを各々T
PS(sodium 3-(trimethylsilyl)-propionate)を基準とし
て測定した値で示した。C13のケミカルシフト値で77.08
ppm及び80.58ppmのシグナルからC-3位の炭素に結合があ
ること、また97.97ppm及び98.32ppmのケミカルシフト値
からC'-1位の炭素にα結合があることが分かる。炭素数
及び配列からフコシルフコースの2糖類であることが分
かり、よって前記化学式4に示されるフコシル−α1,
3−フコースであることが確認された。FIG. 3 shows that the F-1a fraction (fucosyl-α1,
It is a figure which shows CH COSY Spectrum of (3-fucose).
About the result measured at 30 ° C in heavy water, the vertical axis shows D of C13.
ownfield shift, H1 downfield shift on horizontal axis
The values are shown based on PS (sodium 3- (trimethylsilyl) -propionate). 77.08 with chemical shift value of C13
From the signals at ppm and 80.58 ppm, it can be seen that there is a bond at the carbon at the C-3 position, and from the chemical shift values at 97.97 ppm and 98.32 ppm, there is an α bond at the carbon at the C′-1 position. The number of carbon atoms and the sequence indicate that the product is a fucosyl fucose disaccharide, and thus fucosyl-α1,
3-Fucose was confirmed.
【0044】図4は、F−1b画分(キシロシル−β
1,2−フコース)のC-H COSY Spectrum を示す図であ
る。重水中、30℃で測定した結果について、縦軸にC1
3のDownfield shiftを、横軸にH1のDownfield shiftを
各々TPS(sodium 3-(trimethylsilyl)-propionate)を基
準として測定した値で示した。C13のケミカルシフト値
で82.55ppm及び83.44ppmのシグナルからC-2位の炭素に
結合があること、また106.71ppm及び106.76ppmのケミカ
ルシフト値からC'-1位の炭素にβ結合があることが分か
る。炭素数及び配列からキシロシルフコースの2糖類で
あることが分かり、よって前記化学式5に示されるキシ
ロシル−β1,2−フコースであることが確認された。FIG. 4 shows the F-1b fraction (xylosyl-β
It is a figure which shows CH COSY Spectrum of (1, 2-fucose). The vertical axis shows C1 in the results measured at 30 ° C in heavy water.
The Downfield shift of No. 3 was shown on the horizontal axis, and the Downfield shift of H1 was measured by using TPS (sodium 3- (trimethylsilyl) -propionate) as a reference. From the signals of 82.55 ppm and 83.44 ppm in the chemical shift value of C13, there is a bond at the carbon at position C-2, and from the chemical shift values of 106.71 ppm and 106.76 ppm, there is a β bond at the carbon at position C'-1. I understand. The carbon number and the sequence revealed that the product was a xylosyl fucose disaccharide, and thus it was confirmed that the product was xylosyl-β1,2-fucose represented by the above Chemical Formula 5.
【0045】[0045]
【発明の効果】以上説明したように、本発明によれば、
化学合成では調製が困難である前記化学式3及び化学式
4に示されるようなフコース含有オリゴ糖、又はそれを
含有するオリゴ糖組成物を、天然物であるフコイダンを
加水分解することによって容易にかつ効率よく製造する
ことができる。As described above, according to the present invention,
The fucose-containing oligosaccharides or the oligosaccharide compositions containing the fucose-containing oligosaccharides, which are difficult to prepare by chemical synthesis, as shown in the chemical formulas 3 and 4, can be easily and efficiently obtained by hydrolyzing fucoidan, which is a natural product. Can be manufactured well.
【0046】また、本発明により得られるフコース含有
オリゴ糖又はそれを含有するオリゴ糖組成物は、上記の
ように天然物を加水分解して得られ、しかも構造が明確
であるため、食品素材として利用することができると共
に、フコイダン関連化合物分解酵素の活性測定用基質
や、糖鎖工学分野における合成原料等としても用いるこ
とができる。The fucose-containing oligosaccharide or the oligosaccharide composition containing the same obtained by the present invention is obtained by hydrolyzing a natural product as described above, and has a clear structure. In addition to being usable, it can be used as a substrate for measuring the activity of a fucoidan-related compound-degrading enzyme, a synthetic raw material in the field of sugar chain engineering, and the like.
【図1】 Dowex1×4カラム素通り画分を活性炭
−セライトカラムクロマトグラフィーにより分離したク
ロマトグラムを示す図である。FIG. 1 is a view showing a chromatogram obtained by separating a fraction passing through a Dowex 1 × 4 column by activated carbon-celite column chromatography.
【図2】 F−1画分(2糖画分)を分取HPLCクロ
マトグラフィーにより分離したクロマトグラムを示す図
である。FIG. 2 is a view showing a chromatogram obtained by separating an F-1 fraction (a disaccharide fraction) by preparative HPLC chromatography.
【図3】 F−1a画分(フコシル−α1,3−フコー
ス)のH1,C13−NMRスペクトルを示す図であ
る。FIG. 3 is a view showing an H1, C13-NMR spectrum of an F-1a fraction (fucosyl-α1,3-fucose).
【図4】 F−1b画分(キシロシル−β1,2−フコ
ース)のH1,C13−NMRスペクトルを示す図であ
る。FIG. 4 is a view showing an H1, C13-NMR spectrum of an F-1b fraction (xylosyl-β1,2-fucose).
フロントページの続き (51)Int.Cl.7 識別記号 FI テーマコート゛(参考) C07H 3/06 C07H 3/06 // A61K 35/80 A61K 35/80 Z Fターム(参考) 4B018 MD31 MD67 ME14 MF01 MF10 4C057 AA05 BB03 BB04 CC01 4C086 AA03 AA04 EA01 MA04 MA52 MA63 NA14 ZA66 ZB35 ZC20 4C088 AA13 BA12 CA14 CA22 ZA66 ZB35 ZC20 Continued on the front page (51) Int.Cl. 7 Identification symbol FI Theme coat II (reference) C07H 3/06 C07H 3/06 // A61K 35/80 A61K 35/80 Z F term (reference) 4B018 MD31 MD67 ME14 MF01 MF10 4C057 AA05 BB03 BB04 CC01 4C086 AA03 AA04 EA01 MA04 MA52 MA63 NA14 ZA66 ZB35 ZC20 4C088 AA13 BA12 CA14 CA22 ZA66 ZB35 ZC20
Claims (5)
ズク科(Spermatochnaceae)の海藻から抽出して得られ
るフコイダンを酸加水分解後、フコース含有オリゴ糖又
はその組成物を分離精製することを特徴とするフコース
含有オリゴ糖又はその組成物の製造法。1. A fucose-containing oligosaccharide or a fucose-containing composition characterized by separating and purifying a fucose-containing oligosaccharide or a composition thereof after acid hydrolysis of fucoidan obtained by extracting from seaweeds of the family Pineaceae (Chordariaceae) or Spermatochnaceae. A method for producing an oligosaccharide or a composition thereof.
macystis decipiens (Suringar) Kuckuck)を使用する
請求項1に記載のフコース含有オリゴ糖又はその組成物
の製造法。2. As the seaweed, mozuku (Ne mozuku) of the family Mozuku
The method for producing a fucose-containing oligosaccharide or a composition thereof according to claim 1, wherein macystis decipiens (Suringar) Kuckuck) is used.
物が、下記化学式1で表されるフコシル−α1,3−フ
コース又はそれを含有するオリゴ糖組成物である請求項
1又は2に記載のフコース含有オリゴ糖又はその組成物
の製造法。 【化1】 3. The fucose according to claim 1, wherein the fucose-containing oligosaccharide or a composition thereof is fucosyl-α1,3-fucose represented by the following chemical formula 1 or an oligosaccharide composition containing the same. A method for producing an oligosaccharide or a composition thereof. Embedded image
物が、下記化学式2で表されるキシロシル−β1,2−
フコース又はそれを含有するオリゴ糖組成物である請求
項1〜3のいずれか1つに記載のフコース含有オリゴ糖
又はその組成物の製造法。 【化2】 4. The method according to claim 1, wherein the fucose-containing oligosaccharide or the composition thereof is xylosyl-β1,2- represented by the following chemical formula 2.
The method for producing a fucose-containing oligosaccharide or a composition thereof according to any one of claims 1 to 3, which is fucose or an oligosaccharide composition containing the same. Embedded image
1,2−フコース又はそれを含有するオリゴ糖組成物で
あることを特徴とするフコース含有オリゴ糖又はその組
成物。 【化3】 5. Xylosyl-β represented by the following chemical formula 3:
A fucose-containing oligosaccharide or a composition thereof, which is 1,2-fucose or an oligosaccharide composition containing the same. Embedded image
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP11159715A JP2000351790A (en) | 1999-06-07 | 1999-06-07 | Production of fucose-containing oligosaccharide, or its composition and fucose-containing oligosaccharide or its composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP11159715A JP2000351790A (en) | 1999-06-07 | 1999-06-07 | Production of fucose-containing oligosaccharide, or its composition and fucose-containing oligosaccharide or its composition |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2000351790A true JP2000351790A (en) | 2000-12-19 |
Family
ID=15699711
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP11159715A Pending JP2000351790A (en) | 1999-06-07 | 1999-06-07 | Production of fucose-containing oligosaccharide, or its composition and fucose-containing oligosaccharide or its composition |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2000351790A (en) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001039731A1 (en) * | 1999-11-30 | 2001-06-07 | Takara Bio Inc. | Cosmetics |
WO2007013609A1 (en) * | 2005-07-29 | 2007-02-01 | Suntory Limited | Fucoidan-derived oligosaccharide |
WO2006102108A3 (en) * | 2005-03-18 | 2007-03-08 | Supranaturals Llc | Fucoidan compositions and methods for dietary and nutritional supplements |
CN1305885C (en) * | 2004-12-31 | 2007-03-21 | 中国科学院海洋研究所 | Method for preparing L-fucoidan in sea tangle |
WO2008090631A1 (en) * | 2007-01-26 | 2008-07-31 | Suntory Holdings Limited | Fucoidan-derived oligosaccharide |
EP2728009A1 (en) | 2012-10-31 | 2014-05-07 | Jennewein Biotechnologie GmbH | Process for producing monosaccharides |
JP2016088859A (en) * | 2014-10-31 | 2016-05-23 | 第一産業株式会社 | Cream for external use |
EP3050973A1 (en) | 2015-01-30 | 2016-08-03 | Jennewein Biotechnologie GmbH | Fermentation process for producing monosaccharides in free form from nucleotide-activated sugars |
WO2019101629A1 (en) | 2017-11-21 | 2019-05-31 | Jennewein Biotechnologie Gmbh | Process for the purification of l-fucose from a fermentation broth |
CN110128202A (en) * | 2019-05-31 | 2019-08-16 | 襄阳农博源农业有限公司 | A kind of biological organic fertilizer and preparation method thereof |
-
1999
- 1999-06-07 JP JP11159715A patent/JP2000351790A/en active Pending
Non-Patent Citations (1)
Title |
---|
JPN6009063494, 生体認識機能を持つ新糖鎖素材の創製に関する地域基盤研究, 1998, pp.130−138,129 * |
Cited By (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3831252B2 (en) * | 1999-11-30 | 2006-10-11 | タカラバイオ株式会社 | Cosmetics |
US7678368B2 (en) | 1999-11-30 | 2010-03-16 | Takara Bio Inc. | Fucoidan-containing cosmetics |
WO2001039731A1 (en) * | 1999-11-30 | 2001-06-07 | Takara Bio Inc. | Cosmetics |
CN1305885C (en) * | 2004-12-31 | 2007-03-21 | 中国科学院海洋研究所 | Method for preparing L-fucoidan in sea tangle |
US7749545B2 (en) | 2005-03-18 | 2010-07-06 | Sakura Properties, Llc | Fucoidan compositions and methods for dietary and nutritional supplements |
WO2006102108A3 (en) * | 2005-03-18 | 2007-03-08 | Supranaturals Llc | Fucoidan compositions and methods for dietary and nutritional supplements |
EA014421B1 (en) * | 2005-03-18 | 2010-12-30 | СУПРАНЭЧУРАЛС, Эл-Эл-Си | Hydrolyzed fucoidan composition and methods for dietary supplement |
JP2008532555A (en) * | 2005-03-18 | 2008-08-21 | スープラナチュラルズ・エルエルシー | Fucoidan compositions and methods for health and nutritional supplements |
WO2007013609A1 (en) * | 2005-07-29 | 2007-02-01 | Suntory Limited | Fucoidan-derived oligosaccharide |
JPWO2008090631A1 (en) * | 2007-01-26 | 2010-05-13 | サントリーホールディングス株式会社 | Fucoidan-derived oligosaccharides |
WO2008090631A1 (en) * | 2007-01-26 | 2008-07-31 | Suntory Holdings Limited | Fucoidan-derived oligosaccharide |
EP2728009A1 (en) | 2012-10-31 | 2014-05-07 | Jennewein Biotechnologie GmbH | Process for producing monosaccharides |
WO2014067696A1 (en) | 2012-10-31 | 2014-05-08 | Jennewein Biotechnologie Gmbh | Process for producing monosacchcarides |
JP2016088859A (en) * | 2014-10-31 | 2016-05-23 | 第一産業株式会社 | Cream for external use |
EP3050973A1 (en) | 2015-01-30 | 2016-08-03 | Jennewein Biotechnologie GmbH | Fermentation process for producing monosaccharides in free form from nucleotide-activated sugars |
WO2016120448A1 (en) | 2015-01-30 | 2016-08-04 | Jennewein Biotechnologie Gmbh | Fermentation process for producing monosaccharides in free form from nucleotide-activated sugars |
WO2019101629A1 (en) | 2017-11-21 | 2019-05-31 | Jennewein Biotechnologie Gmbh | Process for the purification of l-fucose from a fermentation broth |
US11732282B2 (en) | 2017-11-21 | 2023-08-22 | Chr. Hansen HMO GmbH | Process for the purification of L-fucose from a fermentation broth |
CN110128202A (en) * | 2019-05-31 | 2019-08-16 | 襄阳农博源农业有限公司 | A kind of biological organic fertilizer and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101735336B (en) | Oligomeric fucosylated glycosaminoglycan and preparation method thereof | |
CN110437288B (en) | Sea cucumber fucoidin and preparation method and application thereof | |
CN108727509B (en) | Moso bamboo shoot shell arabinogalactan and preparation and application thereof | |
CA2893950A1 (en) | Preparation of poly alpha-1,3-glucan ethers | |
Zheng et al. | Structural elucidation of a polysaccharide from Chrysanthemum morifolium flowers with anti-angiogenic activity | |
US5233033A (en) | Method for production of sialic acid | |
CN1379781A (en) | Novel oligosaccharides, preparation method and pharmaceutical composition containing same | |
US11547719B2 (en) | Acetylation of aloe polysaccharides | |
CN114591448B (en) | Mulberry and phellinus linteus fruiting body manna galactosan and preparation and application thereof | |
JP2000351790A (en) | Production of fucose-containing oligosaccharide, or its composition and fucose-containing oligosaccharide or its composition | |
JP2001505940A (en) | Novel butyrate having antiproliferative activity and pharmaceutical composition containing the same | |
CN112851829B (en) | A fructus Lycii polysaccharide with blood lipid reducing effect | |
Shao et al. | Preparation and characterization of sulfated inulin-type fructans from Jerusalem artichoke tubers and their antitumor activity | |
CN115386013A (en) | Laminaria polysaccharide with strong anticoagulant activity and preparation method and application thereof | |
CN1916030A (en) | Highly sulfated derivatives of k5 polysaccharide and their preparation | |
KR100370929B1 (en) | Preparing Methode for Aqueous Chitosan | |
CN106518934A (en) | Unsaturated hyaluronic acid odd oligosaccharide and preparation method thereof | |
JP2010018607A (en) | Physiologically active polysaccharide and use thereof | |
CN117964790B (en) | Suaeda salsa polysaccharide and preparation method and application thereof | |
CN115043956B (en) | Sambucus williamsii polysaccharide, polysaccharide composition and application thereof | |
JPH08119986A (en) | Method for purifying sialic acid or its analog | |
JPS58129001A (en) | Novel immunoligically active polyglucide and its preparation | |
CN118307689A (en) | Novel pomegranate rind polysaccharide and preparation method and application thereof | |
JP2004196693A (en) | Method for producing chondrosine | |
JP2002293803A (en) | Antivirus agent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20060605 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20091215 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20100427 |